The performance characteristics of the XE-2100 (Sysmex, Kobe, Japan) 
60 from healthy adult volunteers. The sample from any given patient was analyzed only once by each method. All samples were analyzed within 8 hours of collection, first on the Sysmex XE-2100 analyzer and then by flow cytometry. The samples were analyzed by the XE-2100 in the closed mode except rarely, when only small quantities were available, in which case they were analyzed in open (capillary) mode.
Three levels of commercial quality control specimens (eCheck, Sysmex) were run daily on the XE-2100. The XE-2100 performed a differential count by a combination of light scatter and fluorescence emission. An aliquot of blood is diluted after lysis of RBCs and incubated with a polymethinebased RNA-and DNA-binding fluorescent dye. The cells are analyzed in an optical block using a semiconductor laser. Neutrophils, eosinophils, monocytes, and lymphocytes are differentiated on the basis of their light scatter and fluorescence emission characteristics using electronic cluster analysis protocols. To enable analysis of IGs, the XE Pro software module (Sysmex) has to be added to the XE-2100. The basic XE Pro module enhances reagent management, printing of graphic data, output of analysis data, and quality management. The XE IG Master submodule (Sysmex) electronically determines the cluster of IGs from the granulocyte cluster on the differential histogram. IGs are recognized by their increased fluorescence emission compared with segmented neutrophils because they contain more RNA and DNA. The IG Pro software determines the center of the long axis of the granulocyte cluster, calculates the lower half of the cluster, and uses a mirror image of this to complete the upper half of an ellipse representing mature neutrophils. All events above this ellipse are enumerated as IGs. These events with higher fluorescence represent the higher RNA and DNA content of IGs.
Flow cytometric enumeration of IGs was performed using the method of Fujimoto et al. 4 Briefly, K 3 EDTA anticoagulated blood was incubated for 30 minutes with CD16-fluorescein isothiocyanate, CD11b-phycoerythrin, and CD45-peridinin chlorophyll protein for 30 minutes in the dark at room temperature. Flow cytometric analysis was performed within 60 minutes of sample preparation on an Epics XL-MCL flow cytometer (Beckman Coulter, Brea, CA). At least 10,000 events were counted for each sample. After sequential gating using CD45/side scatter to separate granulocytes and eosinophils from lymphocytes, monocytes, basophils, and debris and CD16 to separate neutrophils from eosinophils, IGs were identified by CD16/CD11b gating. IGs were recognized by the lack of staining for CD16. CD11b was positive in some of these cells (least IGs) but not in the early IGs. The IG count was expressed as a percentage of the total WBC count. The absolute count was derived by using the total WBC count obtained from the XE-2100.
Manual differential cell counting was performed according to the National Committee for Clinical Laboratory Standards (NCCLS) H20-A protocol. 5 Three blood films were prepared by a wedge technique and stained with a modified Wright stain within 2 hours of receipt in the laboratory. The slides were randomly assigned to 2 experienced laboratory technologists who performed a 200-cell differential count. The third blood film was used for arbitration if there were discordant results between the 2 technologists. The total of promyelocytes, myelocytes, and metamyelocytes was included as the IG count. The percentage count was obtained from the combined 400-cell count. The absolute count was derived by using the total WBC count obtained from the XE-2100.
Within-Run Imprecision (Reproducibility) Using Fresh Blood Samples
Within-run imprecision (reproducibility) using fresh blood samples was performed in 3 different samples of blood. Each sample was run 10 consecutive times in the open and closed modes. The mean, SD, and coefficient of variation were determined for the IG absolute and proportional counts.
Long-Term Imprecision Using Quality Control Material
Long-term imprecision was determined in accordance with the protocols in the NCCLS document EP5-A 6 and using commercial quality control materials (e-Check). Three levels of quality control material were run in duplicate 3 times per day for a period of 30 days. The first and last runs were used for calculating within-run and total imprecision as described in NCCLS document EP5-A. The mean, SD, and coefficient of variation of the within-run and total imprecision were determined.
Stability
Short-term stability was assessed by measuring 10 samples immediately after the blood was drawn and after 5, 15, 30, and 60 minutes of storage at room temperature. Long-term stability was assessed with samples stored at room temperature and at 4°C through 8°C (refrigerated). Ten samples were assayed after 4, 8, 12, 24, 36, 48, 56 , and 72 hours.
Reference Range
The reference range was generated from 60 samples obtained from healthy adult volunteers (30 men and 30 women).
Results
The results for within-run imprecision (reproducibility) using fresh blood samples are shown in ❚Table 1❚ and ❚Table 2❚ for 3 samples. Table 1 shows results for samples assayed by the open mode and Table 2 for samples assayed by the closed mode.
The results for imprecision performed on quality control material are shown on ❚Table 3❚ and ❚Table 4❚. Table 3 shows the results for within-run imprecision and Table 4 for total imprecision. A total of 10 specimens were analyzed for short-term stability. The results for this analysis are shown in ❚Figure 1❚.
Long-term stability was analyzed in 10 samples kept at room temperature and 10 samples kept at 4°C (refrigerated). One of the samples at room temperature and 2 of the samples at 4°C were excluded because data were not available for the entire 72-hour period. The results of the long-term stability study are shown in ❚Figure 2❚.
Of the 263 samples analyzed for comparison of the XE-2100, manual microscopy, and flow cytometric methods for counting IGs, 18 were excluded from all 3 data sets because incomplete data were available and 1 sample was excluded as an outlier. Another 15 samples were excluded from the flow cytometric data set because the data were incomplete. For comparisons between the manual count and the XE-2100 and flow cytometric counts, only samples in which the XE-2100 count was more than 0.25% were used; there would be an artifactual proportional bias below this range if all samples were used because a 400-cell count can only count down to 0.25%. Thus, 201 samples were available for comparison between the XE-2100 and manual counts, 229 samples for comparison between the XE-2100 and flow cytometric counts, and 186 samples for comparison between manual and flow cytometric counts. The method comparisons were performed using linear regression analysis and PassingBablok regression analysis. The results of the method comparisons using linear regression analysis are shown in ❚Figure 3❚. The results of the method comparisons using Passing-Bablok regression analysis are shown in ❚Figure 4❚ and ❚Table 5❚.
A total of 60 samples from healthy adult volunteers (30 men and 30 women) were analyzed to establish a reference range. Two samples were excluded because they were neutropenic. The results of the reference range study on the remaining 58 samples are shown in ❚Table 6❚.
Discussion
The origins of the differential cell count can be traced to the pioneering work of Ehrlich and Romanovsky toward the end of the 19th century. 7 By using synthetic dyes to stain peripheral blood films, they demonstrated the existence of morphologically different WBC populations. By the early to mid 20th century, enumeration of these cells in the form of a manual leukocyte differential cell count became an integral part of laboratory testing. The introduction of automated cell counting in the latter part of the 20th century culminated in the routine use of the automated 5-part WBC differential count in the clinical laboratory. Because the automated differential count is more precise and less labor-intensive than the manual differential count, 2, 8 it has resulted in the twin benefits of improved quality and reduced costs in the clinical laboratory. A major limitation of the conventional automated 5-part differential count is the inability to identify cells not normally found in the peripheral blood, such as IGs, or that are present in such small numbers that they are not detected in the usual 100-or 200-cell differential count. The availability of automated identification and counting of IGs offers the possibility of further improvements in quality and costs in the laboratory.
In this study, we evaluated the performance characteristics of the automated IG count performed by the Sysmex XE-2100 analyzer. A comparison of the XE-2100 IG count with the manual count of promyelocytes, myelocytes, and metamyelocytes using linear regression revealed a correlation coefficient of 0.80 for percentage counts. When the manual count was converted to an absolute count by using the total WBC count obtained by the analyzer and correlated by using the absolute IG count of the XE-2100, the correlation coefficient was 0.82. This indicates a strong relationship between the 2 methods of counting IGs and validates the replacement of the traditional manual microscopic IG count by the XE-2100 IG count. The high degree of imprecision of the manual differential count has been well documented in the literature. 9, 10 This problem is magnified when the number of events counted is small, as is the case with IGs. 11, 12 The manual count is, therefore, unsuitable and inappropriate as a reference method for counting rare events such as IGs. To address this problem, many investigators have attempted to devise alternative reference methods for enumeration of IGs by using flow cytometry. Pioneering investigations by Terstappen et al 13 and LundJohansen and Terstappen 14 using flow cytometry demonstrated differential expression of antigens on granulocytes during maturation. Thus, CD16 is expressed only in mature neutrophils, not in IGs, whereas CD11b is expressed on some IGs but not in the very early stages. CD45 is expressed during all stages of granulocyte maturation. Several workers have used anti-CD16 in combination with other antibodies against leukocyte antigens to identify IGs in peripheral blood. [15] [16] [17] Fujimoto et al 4 described a flow cytometric method using anti-CD16, anti-CD11b, and anti-CD45 to identify IGs and demonstrated good correlation between this assay and microscopy of sorted cells. This method represents a potential reference method for enumeration of IGs.
In our comparison of the flow cytometric IG count with the XE-2100 IG count using linear regression, there was excellent correlation between the 2 (correlation coefficients of 0.93 and 0.95 for absolute and proportional counts, respectively). This indicates a strong relationship between the XE-2100 IG count and the proposed flow cytometric reference method and validates its use in clinical practice. There was also good correlation between the XE-2100 and manual counts (correlation coefficients of 0.82 and 0.80 for absolute and proportional counts, respectively). There was also acceptable correlation between the proposed flow cytometric reference method and the manual method (correlation coefficients of 0.70 and 0.78 for absolute and proportional counts, respectively). However, it is recognized that there are serious flaws when using least squares linear regression to perform method comparisons between 2 laboratory analytic methods. 18 The most serious flaw is that this statistical analysis assumes that the reference method is measured without error. This condition patently does not hold for the manual differential count. It also assumes that the SE of the new method is normally distributed and constant for the entire measurement range. There are virtually no clinical laboratory tests that can meet these conditions.
To overcome these difficulties, it has been recommended that a more robust statistical procedure, the Passing-Bablok regression analysis, be used for method comparison of clinical laboratory methods. 19 This nonparametric procedure does not make any assumptions and is not susceptible to the variance of either method.
We compared the different methods of counting IGs by Passing-Bablok regression analysis; the results are shown in Figure 4 and Table 5 . The comparison between the manual microscopic and proposed reference flow cytometric methods shows a discernible linear proportional bias as can be detected by visual inspection of the graphic plot and the fact that the number 1.00 is not within the 99% confidence intervals for the slope. There is a similar linear proportional bias in the comparison between the manual microscopic and XE-2100 methods. The manual microscopic count consistently underestimates the IGs at low counts. This bias is most likely due to the high imprecision of the manual count and the small number of cells counted, which compromises accuracy for cells present in very small numbers.
A notable negative skew is present for the manual count. One possible explanation for this is improper classification of metamyelocytes as band cells and excluding them from the IG count. Band cells are notoriously difficult to classify by manual microscopy. 20 Another possibility is that the flow cytometric count includes some mature neutrophils, thereby producing the skew. However, experiments using cell-sorting procedures have confirmed that the flow cytometric method does not include mature neutrophils. 4 The comparison between the XE-2100 and flow cytometric methods demonstrates complete agreement for the analysis of absolute numbers and a negligible proportional bias for the comparison of percentages. This confirms the superiority of the XE-2100 count over the manual count and validates the use of the flow cytometric method as a reference method for counting IGs.
The NCCLS document "Reference Leukocyte Differential Count (Proportional) and Evaluation of Instrument Methods" 5 has been used for validation of instrumental leukocyte differential counts for more than 10 years. This procedure uses a 400-cell manual count to reduce the variance of the count. However, although it may be acceptable for relatively high proportional counts, it is not suitable for counts of less than 5%. Clearly, as instruments become capable of identifying abnormal cells in the peripheral blood that are present in very small proportions, an alternative reference method for WBC differential counts is required. A flow cytometric method is ideal for this purpose. Fluorescence flow cytometric methods using monoclonal antibodies can be expected to produce the most accurate counts because of their flexibility and ability to gate around specific cell populations. The proposed flow cytometric reference method for counting IGs is eminently suitable for the purpose. A flow cytometric-based method has also been proposed for counting nucleated RBCs in the peripheral blood, 21 and this method has been validated in the field. 22 The IG count showed excellent reproducibility in closed and open modes. The coefficient of variation for reproducibility of the IG count compared favorably with the total WBC count and the absolute and proportional neutrophil counts.
The short-term stability measured for a 1-hour period was excellent. The long-term stability was evaluated for a 72-hour period with specimens left at room temperature or refrigerated. There was good stability at room temperature and with refrigeration for a 24-hour period, and, as can be expected, stability deteriorated in blood samples left at room temperature after that period. The stability of the XE-2100 IG count would be of particular benefit for laboratories with samples shipped in from a long distance.
The long-term imprecision measured for a period of 30 days using a commercial control sample was excellent and comparable to that of the total WBC and proportional counts. The within-run and total imprecision are superior to the manufacturers' claims. The availability of suitable quality control material is certainly an asset for introducing this assay into the clinical laboratory.
The manual differential count is time-consuming and expensive for the laboratory, and laboratories, therefore, rely on instrument "flags" indicating an abnormality may be present to avoid performing manual reviews or differential counts on normal specimens. Analytic instruments provide an "IG" flag to indicate that IGs are potentially present in the peripheral blood. A recent study indicated that this flag was responsible for most of the false-negative (52%) blood film reviews performed in hematology laboratories. 23 The XE-2100 IG count can be expected to eliminate this component of false negativity and further reduce false positivity related to nonspecific flagging. Having an instrument that can accurately count IGs should reduce the unnecessary review of peripheral blood films significantly.
The availability of an automated IG count brings the clinical laboratory an additional step closer to the holy grail of automated cell analysis, ie, a complete, automated, extended differential count of all cells in the peripheral blood. An immediate benefit of this in the clinical laboratory will be the decreased need for a manual differential cell count on CBC specimens that generate an IG flag. Furthermore, the IG count obtained and reported by the instrument will be more accurate and precise than that from a manual count because it is well established that the instrument count is more precise than the manual count. 24 The ability of instruments to count abnormal cells in the peripheral blood rapidly and accurately, even when they are present in very small numbers, portends the end of the manual differential cell count and a new era in the hematology laboratory. The IG count has usefulness in the diagnosis and management of a large number of hematologic and nonhematologic diseases. Many of these associations have been established using manual counting. Further studies using a more accurate and precise IG count offer the opportunity to reevaluate and redefine these associations. Preliminary studies have shown promising results in using the XE-2100 IG count for screening for sepsis and infection. [25] [26] [27] 
